Investors & Media

Press Releases

Date Title View
Toggle Summary SAGE Therapeutics Announces Collaboration with Washington University to Develop Novel GABA Receptor Small Molecules
SAGE Therapeutics Announces Collaboration with Washington University to Develop Novel GABA Receptor Small Molecules
View HTML
Toggle Summary SAGE Therapeutics Presents New Data Identifying Highly Selective, Oral Compounds and Novel Approach for the Treatment of Chronic Epilepsies
SAGE Therapeutics Presents New Data Identifying Highly Selective, Oral Compounds and Novel Approach for the Treatment of Chronic Epilepsies
View HTML
Toggle Summary SAGE's Novel Approach to Treatment of CNS Disorders to be Highlighted at Leading Industry and Scientific Conferences
SAGE's Novel Approach to Treatment of CNS Disorders to be Highlighted at Leading Industry and Scientific Conferences
View HTML
Toggle Summary SAGE Presents New Mechanistic Insights On Novel Approach SAGE Presents New Mechanistic Insights On Novel Approach
SAGE Presents New Mechanistic Insights On Novel Approach SAGE Presents New Mechanistic Insights On Novel Approach
View HTML
Toggle Summary SAGE's Discovery of Novel Allosteric Therapeutic Approach for a Broad Range of CNS Disorders Published in Journal of Neuroscience
SAGE's Discovery of Novel Allosteric Therapeutic Approach for a Broad Range of CNS Disorders Published in Journal of Neuroscience
View HTML
Toggle Summary SAGE Therapeutics Secures $20M Series B Financing
SAGE Therapeutics Secures $20M Series B Financing
View HTML